Published in Life Sci on June 28, 2007
Effect of Coffee and Tea Consumption on Adolescent Weight Control | NCT05181176
Deep sequencing of the Camellia sinensis transcriptome revealed candidate genes for major metabolic pathways of tea-specific compounds. BMC Genomics (2011) 2.84
Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett (2008) 2.13
Green tea catechins and cardiovascular health: an update. Curr Med Chem (2008) 1.58
Beneficial effects of green tea: a literature review. Chin Med (2010) 1.44
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol (2009) 1.33
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr (2008) 1.28
Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs. Toxicology (2009) 1.24
Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer (2012) 1.22
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer (2009) 1.22
Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin Cancer Res (2009) 1.21
Evaluation of the antioxidant properties of fruit and flavoured black teas. Eur J Nutr (2011) 1.16
Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol (2010) 1.14
Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res Ther (2009) 1.13
Differential effects of a green tea-derived polyphenol (-)-epigallocatechin-3-gallate on the acidosis-induced decrease in the Ca(2+) sensitivity of cardiac and skeletal muscle. Pflugers Arch (2008) 1.12
Comparative chloroplast genomes of camellia species. PLoS One (2013) 1.10
Antiartherosclerotic effects of plant flavonoids. Biomed Res Int (2014) 1.09
Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J Nutr (2008) 1.08
Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis (2011) 1.06
Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.00
New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer (2011) 0.98
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis (2013) 0.95
Innovative oral treatments of uterine leiomyoma. Obstet Gynecol Int (2012) 0.94
Nutritional recommendations for cardiovascular disease prevention. Nutrients (2013) 0.94
Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev (2010) 0.93
Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages. Gut Liver (2012) 0.91
Fatty acid composition and antioxidant activity of tea (Camellia sinensis L.) seed oil extracted by optimized supercritical carbon dioxide. Int J Mol Sci (2011) 0.90
Catechin stimulates osteogenesis by enhancing PP2A activity in human mesenchymal stem cells. Osteoporos Int (2010) 0.90
Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci (2015) 0.89
Therapeutic molecular targets in human chondrosarcoma. Int J Exp Pathol (2010) 0.89
Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem Pharmacol (2012) 0.89
Changes of constituents and activity to apoptosis and cell cycle during fermentation of tea. Int J Mol Sci (2011) 0.89
Transcriptomic and phytochemical analysis of the biosynthesis of characteristic constituents in tea (Camellia sinensis) compared with oil tea (Camellia oleifera). BMC Plant Biol (2015) 0.87
Radioprotective effect of epicatechin in cultured human fibroblasts and zebrafish. J Radiat Res (2013) 0.86
Global transcriptome and gene regulation network for secondary metabolite biosynthesis of tea plant (Camellia sinensis). BMC Genomics (2015) 0.85
Black tea extract prevents lipopolysaccharide-induced NF-κB signaling and attenuates dextran sulfate sodium-induced experimental colitis. BMC Complement Altern Med (2011) 0.85
Dietary agents for prevention and treatment of lung cancer. Cancer Lett (2015) 0.85
Entry inhibitors: New advances in HCV treatment. Emerg Microbes Infect (2016) 0.84
Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway. Biomed Res Int (2015) 0.84
Theaflavin Inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 Expression in Bone Marrow-Derived Macrophages Through the Blockade of NF-κB and MAPK Signaling Pathways. Chonnam Med J (2011) 0.83
Pretreatment with black tea polyphenols modulates xenobiotic-metabolizing enzymes in an experimental oral carcinogenesis model. Oncol Res (2008) 0.83
Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway. PLoS One (2012) 0.83
Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells. Inflamm Res (2010) 0.82
Bioconversion of wastewater from sweet potato starch production to Paenibacillus polymyxa biofertilizer for tea plants. Sci Rep (2014) 0.82
Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep (2014) 0.81
Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 mice. J Neurochem (2011) 0.81
Inhibition of Listeria monocytogenes ATCC 19115 on ham steak by tea bioactive compounds incorporated into chitosan-coated plastic films. Chem Cent J (2012) 0.81
Tea consumption and mortality in the oldest-old Chinese. J Am Geriatr Soc (2013) 0.81
Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort. Sci Rep (2016) 0.80
Chronic Administration of Oil Palm (Elaeis guineensis) Leaves Extract Attenuates Hyperglycaemic-Induced Oxidative Stress and Improves Renal Histopathology and Function in Experimental Diabetes. Evid Based Complement Alternat Med (2012) 0.80
Effect of tea theaflavins and catechins on microvascular function. Nutrients (2014) 0.80
Non-Nutrient, Naturally Occurring Phenolic Compounds with Antioxidant Activity for the Prevention and Treatment of Periodontal Diseases. Antioxidants (Basel) (2015) 0.80
Ascorbic acid offsets the inhibitory effect of bioactive dietary polyphenolic compounds on transepithelial iron transport in Caco-2 intestinal cells. J Nutr (2011) 0.80
Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs (2009) 0.80
Construction, characterization, and preliminary BAC-end sequence analysis of a bacterial artificial chromosome library of the tea plant (Camellia sinensis). J Biomed Biotechnol (2010) 0.80
Tea contains potent inhibitors of tyrosine phosphatase PTP1B. Biochem Biophys Res Commun (2011) 0.78
Inhibition of the intracellular Ca(2+) transporter SERCA (Sarco-Endoplasmic Reticulum Ca(2+)-ATPase) by the natural polyphenol epigallocatechin-3-gallate. J Bioenerg Biomembr (2012) 0.78
Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells. Nutrients (2015) 0.78
Short-term weight-centric effects of tea or tea extract in patients with metabolic syndrome: a meta-analysis of randomized controlled trials. Nutr Diabetes (2015) 0.77
Theanine and Caffeine Content of Infusions Prepared from Commercial Tea Samples. Pharmacogn Mag (2016) 0.77
Acetonic and Methanolic Extracts of Heterotheca inuloides, and Quercetin, Decrease CCl(4)-Oxidative Stress in Several Rat Tissues. Evid Based Complement Alternat Med (2013) 0.76
Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int J Nanomedicine (2014) 0.76
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration? Curr Neuropharmacol (2014) 0.76
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate. Liver Transpl (2016) 0.76
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells. Front Pharmacol (2016) 0.76
Systemic Absorption of Catechins after Intraruminal or Intraduodenal Application of a Green Tea Extract in Cows. PLoS One (2016) 0.75
Green tea polyphenols induce cell death in breast cancer MCF-7 cells through induction of cell cycle arrest and mitochondrial-mediated apoptosis. J Zhejiang Univ Sci B (2017) 0.75
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. PLoS One (2016) 0.75
Acute and sub-chronic oral toxicity study of black tea in rodents. Indian J Pharmacol (2015) 0.75
Allograft pretreatment for the repair of sciatic nerve defects: green tea polyphenols versus radiation. Neural Regen Res (2015) 0.75
Effects of green tea extracts on the pharmacokinetics of quetiapine in rats. Evid Based Complement Alternat Med (2015) 0.75
Protective effect of theaflavin on erythrocytes subjected to in vitro oxidative stress. Biochem Res Int (2013) 0.75
Green tea extract does not affect exogenous glucose appearance but reduces insulinemia with glucose ingestion in exercise recovery. J Appl Physiol (1985) (2016) 0.75
Synergisms in Alpha-glucosidase Inhibition and Antioxidant Activity of Camellia sinensis L. Kuntze and Eugenia uniflora L. Ethanolic Extracts. Pharmacognosy Res (2017) 0.75
In vitro Accumulation of Polyphenols in Tea Callus Derived from Anther. Pharmacogn Mag (2016) 0.75
Inhibition of cyclic diadenylate cyclase, DisA, by polyphenols. Sci Rep (2016) 0.75
Effects of stachyose on absorption and transportation of tea catechins in mice: possible role of Phase II metabolic enzymes and efflux transporters inhibition by stachyose. Food Nutr Res (2016) 0.75
Green tea consumption and cause-specific mortality: Results from two prospective cohort studies in China. J Epidemiol (2016) 0.75
Tea (Camellia sinensis) infusions ameliorate cancer in 4TI metastatic breast cancer model. BMC Complement Altern Med (2017) 0.75
Polyphenol Bioaccessibility and Sugar Reducing Capacity of Black, Green, and White Teas. Int J Food Sci (2013) 0.75
Epigallocatechin-3-O-(3-O-methyl)-gallate-induced differentiation of human keratinocytes involves klotho-mediated regulation of protein kinase-cAMP responsive element-binding protein signaling. Int J Mol Sci (2014) 0.75
Binding effect of proline-rich-proteins (PRPs) on in vitro antimicrobial activity of the flavonoids. Braz J Microbiol (2015) 0.75
Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies? Front Pharmacol (2017) 0.75
Evaluation of Camellia sinensis catechins as a swine antimicrobial feed additive that does not cause antibiotic resistance. Microbes Environ (2012) 0.75
Effect of different brewing times on soluble oxalate content of loose-packed black teas and tea bags. Urolithiasis (2012) 0.75
Antimicrobial Intervention by Photoirradiation of Grape Pomace Extracts via Hydroxyl Radical Generation. Front Physiol (2017) 0.75
Protective effects of tea polyphenols on exhaustive exercise-induced fatigue, inflammation and tissue damage. Food Nutr Res (2017) 0.75
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. Cell Death Dis (2017) 0.75
Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med (1995) 3.90
Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr (2003) 3.75
Tea and cancer. J Natl Cancer Inst (1993) 3.31
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr (1999) 3.29
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr (2000) 2.52
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med (1999) 2.09
Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol (2001) 2.03
Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev (1998) 1.87
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res (2004) 1.84
Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer (2004) 1.80
Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res (1995) 1.79
Tea consumption and mortality after acute myocardial infarction. Circulation (2002) 1.76
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72
Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology (2000) 1.72
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res (2005) 1.72
Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) (2005) 1.71
Mechanisms of cancer prevention by tea constituents. J Nutr (2003) 1.68
Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis (2005) 1.66
Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene (2003) 1.62
Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int (1999) 1.59
Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res (2007) 1.58
Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord (2002) 1.57
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res (2005) 1.55
Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res (1992) 1.52
Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res (2003) 1.50
Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord (2000) 1.50
Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol (2002) 1.49
Green tea and risk of breast cancer in Asian Americans. Int J Cancer (2003) 1.48
Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J (2005) 1.45
Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors (2000) 1.43
Molecular targets for green tea in prostate cancer prevention. J Nutr (2003) 1.43
Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem (2003) 1.41
Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys (2003) 1.39
Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res (2003) 1.38
Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis (2005) 1.38
Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer (2005) 1.37
Tea drinking and bone mineral density in older women. Am J Clin Nutr (2000) 1.36
Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res (1998) 1.35
Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer (1997) 1.32
Tea, obesity, and diabetes. Mol Nutr Food Res (2006) 1.30
Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28
Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem (2006) 1.28
The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res (2006) 1.22
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res (2006) 1.21
Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals (2005) 1.21
Antioxidants in tea. Crit Rev Food Sci Nutr (1997) 1.20
Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis (2005) 1.19
Antioxidative properties of black tea. Prev Med (2005) 1.18
Antioxidant flavonols and coronary heart disease risk. Lancet (1997) 1.17
A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci (2001) 1.17
Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem (2001) 1.14
Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res (2005) 1.13
Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem (2005) 1.13
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer (2000) 1.12
Potential therapeutic applications of tea in dermatology. Int J Dermatol (1999) 1.12
Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol (1999) 1.12
Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res (2006) 1.11
Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes. Drug Metab Dispos (2002) 1.10
Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol (1999) 1.10
Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin Cancer Res (2005) 1.10
Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene (2003) 1.08
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr (2003) 1.08
Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr (2004) 1.08
A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology (2001) 1.05
Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res (1998) 1.05
Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res (2004) 1.05
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol (2000) 1.04
A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr (2000) 1.03
Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. Carcinogenesis (2005) 1.03
Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity (Silver Spring) (2007) 1.03
Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med (1999) 1.03
Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis (1998) 1.01
Scavenging mechanisms of (-)-epigallocatechin gallate and (-)-epicatechin gallate on peroxyl radicals and formation of superoxide during the inhibitory action. Free Radic Biol Med (1999) 1.01
Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis (2000) 1.00
Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem (2001) 1.00
Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate. Int J Cancer (2004) 0.99
Dietary habits and lung cancer risk among non-smoking women. Eur J Cancer Prev (2004) 0.98
The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med (1999) 0.97
Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res (2005) 0.97
Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas (2002) 0.95
Inhibitory effect of green and black tea on tumor growth. Proc Soc Exp Biol Med (1999) 0.94
Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol (2001) 0.94
A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res (2006) 0.94
Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin. BMC Dermatol (2001) 0.94
Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev (2004) 0.93
[A case-control study on the dietary risk factors of upper digestive tract cancer]. Zhonghua Liu Xing Bing Xue Za Zhi (1999) 0.93
Can teatime increase one's lifetime? Ageing Res Rev (2003) 0.92
Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis (1997) 0.92
Effects of tea on preneoplastic lesions and cell cycle regulators in rat liver. Cancer Epidemiol Biomarkers Prev (2002) 0.92
Is green tea good for HIV-1 infection? J Allergy Clin Immunol (2003) 0.91
Consumption of tea and coffee and the risk of lung cancer in cigarette-smoking men: a case-control study in Uruguay. Lung Cancer (1998) 0.90
Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer (1996) 0.89
Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters. Nutr Cancer (1999) 0.88
Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis (1989) 0.88
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17
Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal (2008) 2.36
Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett (2008) 2.13
Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J Invest Dermatol (2011) 1.97
S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Proc Natl Acad Sci U S A (2006) 1.87
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res (2004) 1.84
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A (2005) 1.78
Curcumin for chemoprevention of colon cancer. Cancer Lett (2007) 1.75
Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev (2007) 1.74
Dietary agents for chemoprevention of prostate cancer. Cancer Lett (2008) 1.72
Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis (2010) 1.67
Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer (2005) 1.63
Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene (2003) 1.62
Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase. J Biol Chem (2011) 1.60
Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res (2007) 1.58
Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene (2002) 1.58
Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp Dermatol (2006) 1.57
Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res (2009) 1.57
Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis (2006) 1.51
Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem (2006) 1.51
Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. J Biol Chem (2006) 1.51
A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. J Nucl Med (2003) 1.49
Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis. J Invest Dermatol (2006) 1.49
A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis (2008) 1.47
Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res (2005) 1.47
Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem (2006) 1.47
Cannabinoids for cancer treatment: progress and promise. Cancer Res (2008) 1.46
Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J (2005) 1.45
Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Res (2004) 1.45
Molecular targets for green tea in prostate cancer prevention. J Nutr (2003) 1.43
Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat Res (2005) 1.43
Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett (2003) 1.42
A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev (2006) 1.41
Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res (2009) 1.40
Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys (2003) 1.39
Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res (2007) 1.38
Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer (2005) 1.37
Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene (2004) 1.36
A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. Cancer Res (2008) 1.36
Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis (2008) 1.36
Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett (2010) 1.35
Lupeol modulates NF-kappaB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene (2004) 1.29
Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol (2002) 1.28
Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene (2003) 1.27
Apoptosis by dietary agents for prevention and treatment of prostate cancer. Endocr Relat Cancer (2010) 1.26
Tea beverage in chemoprevention of prostate cancer: a mini-review. Nutr Cancer (2003) 1.23
Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer (2009) 1.22
Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin Cancer Res (2009) 1.21
Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis (2005) 1.19
Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol (2005) 1.19
Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer (2011) 1.18
Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther (2004) 1.17
Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis (2006) 1.17
Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis (2010) 1.17
Prostate cancer prevention through pomegranate fruit. Cell Cycle (2006) 1.17
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis (2011) 1.16
Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J Clin Oncol (2003) 1.15
A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res (2008) 1.15
A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Cancer Res (2005) 1.14
Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res (2008) 1.14
Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res (2005) 1.13
Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res (2011) 1.12
Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin Cancer Res (2008) 1.12
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J (2010) 1.11
Apoptosis by dietary agents for prevention and treatment of cancer. Biochem Pharmacol (2008) 1.11
Keratin gene mutations in disorders of human skin and its appendages. Arch Biochem Biophys (2010) 1.10
Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145. Carcinogenesis (2006) 1.10
Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal (2012) 1.10
Tea and health: studies in humans. Curr Pharm Des (2013) 1.10
Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis (2005) 1.09
Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem Photobiol (2012) 1.09
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer (2005) 1.09
Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene (2003) 1.08
Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther (2014) 1.08
Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol Appl Pharmacol (2003) 1.07
Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials (2013) 1.07
SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc Natl Acad Sci U S A (2007) 1.07
Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis (2011) 1.06
Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol (2007) 1.06
Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Chem Biol Interact (2007) 1.05
Impact of nanotechnology in cancer: emphasis on nanochemoprevention. Int J Nanomedicine (2012) 1.05
Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) (2010) 1.05
Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci (2002) 1.04
Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem (2004) 1.03
Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB. Int J Cancer (2009) 1.03
What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer? Dis Colon Rectum (2007) 1.03
Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. Carcinogenesis (2011) 1.03
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. Photochem Photobiol (2008) 1.02
YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule fisetin. Oncotarget (2014) 1.02
Beneficial effects of tea and its polyphenols against prostate cancer. Mol Nutr Food Res (2006) 1.02
Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res (2009) 1.02
Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer (2009) 1.01
Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin. Anticancer Agents Med Chem (2013) 1.00
Circadian rhythm connections to oxidative stress: implications for human health. Antioxid Redox Signal (2013) 1.00
Polyphenols from green tea and pomegranate for prevention of prostate cancer. Free Radic Res (2006) 0.99
Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res (2010) 0.99
Caecal volvulus following abdominoplasty: a tale of caution. BMJ Case Rep (2014) 0.98
Photochemoprevention of skin cancer by botanical agents. Photodermatol Photoimmunol Photomed (2003) 0.98
Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate (2008) 0.98